Skip to main content

Table 1 Clinical characteristics of EOC patients with high and low GAS5 risk scores

From: Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

 

Case(n)

GAS5

P

Low-risk (n)

High-risk (n)

Age

  ≥ mean

33

17

16

0.269

  < mean

20

8

12

 

FIGO Stage

 I- II

22

16

6

0.007*

 III-IV

31

10

21

 

Histological Type

 I

11

7

4

0.024*

 II- III

42

16

26

 

Residual tumor (cm)

  < 1 cm

34

18

16

0.332

  ≥ 1 cm

19

8

11

 

Histology

 Mucinous

7

3

4

0.402

 Serous

41

17

24

 

 Endometrioid

3

1

2

 

 Clear cell

2

1

1

 

Lymphatic metastasis

 No

20

8

12

0.257

 Yes

33

14

19

 

Ascites

 No

21

14

7

0.096

 Yes

32

13

19

 
  1. P Values are calculated by X2 test or Fisher’s exact test
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us